Bayesian Capital Management’s Amgen AMGN Stock Holding History

Bayesian Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$863K	Buy	+2,384	New	+$816K	0.55%	54
2025 Q1	–	Sell	-43,000	Closed	-$11.2M	–	595
2024 Q4	$11.2M	Buy	+43,000	New	+$12.8M	1.37%	2
2024 Q3	–	Sell	-12,022	Closed	-$3.76M	–	656
2024 Q2	$3.76M	Buy	12,022 +4,700	+64%	+$1.38M	0.43%	46
2024 Q1	$2.08M	Buy	+7,322	New	+$2.14M	0.2%	147
2023 Q4	–	Sell	-16,400	Closed	-$4.41M	–	728
2023 Q3	$4.41M	Sell	16,400 -2,000	-11%	-$499K	0.5%	45
2023 Q2	$4.09M	Buy	18,400 +13,500	+276%	+$3.13M	0.44%	37
2023 Q1	$1.18M	Buy	+4,900	New	+$1.2M	0.15%	208
2022 Q2	–	Sell	-4,300	Closed	-$1.04M	–	767
2022 Q1	$1.04M	Buy	+4,300	New	+$988K	0.16%	202
2020 Q1	–	Sell	-880	Closed	-$212K	–	765
2019 Q4	$212K	Buy	+880	New	+$194K	0.04%	521
2019 Q1	–	Sell	-9,900	Closed	-$1.93M	–	537
2018 Q4	$1.93M	Buy	+9,900	New	+$1.93M	0.39%	47
2018 Q2	–	Sell	-10,400	Closed	-$1.77M	–	585
2018 Q1	$1.77M	Buy	+10,400	New	+$1.91M	0.45%	31
2017 Q2	–	Sell	-14,423	Closed	-$2.37M	–	415
2017 Q1	$2.37M	Buy	+14,423	New	+$2.4M	1.12%	2

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bayesian Capital Management's AMGN Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Amgen (AMGN) in Q2 2026: 2,384 shares worth $863K. The stake represents 0.55% of the portfolio and ranks #54 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in AMGN as recently as Q4 2024.

Bayesian Capital Management first reported a position in AMGN in Q1 2017 and has held it in 12 quarters since. The position peaked at $11.2M in Q4 2024. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Bayesian Capital Management held 2,384 shares of Amgen worth $863K as of Q2 2026.
Amgen was a new Bayesian Capital Management position in Q2 2026.
Amgen made up 0.55% of Bayesian Capital Management's portfolio in Q2 2026, its #54 holding.
Bayesian Capital Management first reported a position in Amgen in Q1 2017 and has held it in 12 quarters since.
Bayesian Capital Management's Amgen position peaked at $11.2M in Q4 2024.
3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.